Transdermal drug delivery: Overcoming the skin's barrier function

Pharmaceutical Science and Technology Today

Volumn 3, Issue 9, 2000, Pages 318-326

  Naik, Aarti ^a,b   Kalia, Yogeshvar N ^a   Guy, Richard H ^a  

^a Ctr Interuniv de Rech et d'E   (France)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; ESTRADIOL; FENTANYL; GLYCERYL TRINITRATE; NICOTINE; SCOPOLAMINE; TESTOSTERONE;

DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG TRANSPORT; ELECTROPORATION; HUMAN; IONTOPHORESIS; LIPOPHILICITY; REVIEW; SKIN PENETRATION; ULTRASOUND;

EID: 0034282141     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1461-5347(00)00295-9     Document Type: Review

References (83)

1. 1 Blank, I.H. (1965) Cutaneous barriers. J. Invest. Dermatol. 45, 249-256
2. 2 Scheuplein, R.J. and Blank, I.H. (1971) Permeability of the skin. Physiol. Rev. 51, 702-747
3. 3 Christophers, E. (1971) Cellular architecture of the stratum corneum. J. Invest. Dermatol. 56, 165-169
4. 4 Elias, P.M. (1981) Lipids and the epidermal permeability barrier. Arch. Dermatol. Res. 270, 95-117
5. 5 Elias, P.M. (1983) Epidermal lipids, barrier function, and desquamation. J. Invest. Dermatol. 80, 44-49
6. 6 Gray, G. et al. (1982) Lipid composition of the superficial stratum corneum cells of the epidermis. Br. J. Dermatol. 106, 59-63
7. 7 Williams, M. and Elias, P. (1987) The extracellular matrix of stratum corneum: role of lipids in normal and pathological function. CRC Crit. Rev. Ther. Drug Carrier Syst. 3, 95-122
8. 8 Potts, R.O. and Francoeur, M.L. (1991) The influence of stratum corneum morphology on water permeability. J. Invest. Dermatol. 96, 495-499
9. 9 Nemanic, M.K. and Elias, P.M. (1980) In situ precipitation: a novel cytochemical technique for visualization of permeability pathways in mammalian stratum corneum. J. Histochem. Cytochem. 28, 573-578
10. 10 Boddé, H.E. et al. (1991) Visualization of in vitro percutaneous penetration mercuric chloride; transport through intercellular space versus cellular uptake through desmosomes. J. Control. Release 15, 227-236
11. 11 Turner, N.G. and Guy, R.H. (1997) Iontophoretic transport pathways: dependence on penetrant physicochemical properties. J. Pharm. Sci. 86, 1385-1389
12. 12 Albery, W.J. and Hadgraft, J. (1979) Percutaneous absorption: in vivo experiments. J. Pharm. Pharmacol. 31, 140-147
13. 13 Golden, G.M. et al. (1987) Role of stratum corneum lipid fluidity in transdermal drug flux. J. Pharm. Sci. 76, 25-28
14. 14 Potts, R.O. and Francoeur, M.L. (1990) Lipid biophysics of water loss through the skin. Proc. Natl. Acad. Sci. U. S. A. 87, 3871-3873
15. 15 Einstein, A. (1926) Investigations on the Theory of the Brownian Movement, Methuen
16. 16 Stein, W. (1986) Transport and Diffusion Across Cell Membranes, Academic Press
17. 17 Kasting, G. et al. (1987) Skin Pharmacokinetics (Shroot, B. and Schaefer, H., eds), Karger
18. 18 Potts, R.O. and Guy, R.H. (1992) Predicting skin permeability. Pharm. Res. 9, 663-669
19. 19 Guy, R. and Potts, R. (1993) Penetration of industrial chemicals across the skin: a predictive model. Am. J. Ind. Med. 23, 711-719
20. 20 Flynn, G.L. et al. (1974) Mass transport phenomena and models: theoretical concepts. J. Pharm. Sci. 63, 479-510
21. 21 Higuchi, T. (1960) Physical chemical analysis of percutaneous absorption process from creams and ointments. J. Soc. Cosmet. Chem. 11, 85-97
22. 22 Davis, A. and Hadgraft, J. (1993) Supersaturated solutions as topical drug delivery systems. In Pharmaceutical Skin Penetration Enhancement (Walters, K. and Hadgraft, J., eds), pp. 243-267, Marcel Dekker
23. 23 Osborne, D. et al. (1990) Surfactant association colloids as topical drug delivery vehicles. In Topical Drug Delivery Formulations (Osborne, D., ed.), pp. 349-379, Marcel Dekker
24. 24 Uster, P. (1990) Liposome-based vehicles for topical delivery. In Topical Drug Delivery Formulations (Osborne, D., ed.), pp. 327-348, Marcel Dekker
25. 25 Sloan, K. (1992) Prodrugs,Topical and Ocular Delivery, Marcel Dekker
26. 26 Walters, K.A. and Hadgraft, J. (1993) Pharmaceutical Skin Penetration Enhancement, Marcel Dekker
27. 27 Smith, E.W. and Maibach, H.I. (1995) Percutaneous Penetration Enhancers, CRC Press
28. 28 Kai, T. et al. (1990) Mechanism of percutaneous penetration enhancement: effect of n-alkanols on the permeability barrier of hairless mouse skin. J. Control. Release 12, 103-112
29. 29 Bommannan, D. et al. (1991) Examination of the effect of ethanol on human stratum corneum in vivo using infrared spectroscopy. J. Control. Release 16, 299-304
30. 30 Ongpipattanakul, B. et al. (1991) Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm. Res. 8, 350-354
31. 31 Naik, A. et al. (1995) Mechanism of oleic-acid induced skin penetration enhancement in vivo in humans. J. Control. Release 37, 299-306
32. 32 Lieckfeldt, R. et al. (1994) Influence of oleic acid on the structure of a mixture of hydrated model stratum corneum fatty acids and their soaps. Colloids Surf. A Physiochem. Eng. Aspects 90, 225-234
33. 33 Mak, V.H. et al. (1991) Does hydration affect intercellular lipid organization in the stratum corneum? Pharm. Res. 8, 1064-1065
34. 34 Bouwstra, J.A. et al. (1991) Thermodynamic and structural aspects of the skin barrier. J. Control. Release 15, 209-220
35. 35 Hadgraft, J. et al. (1985) Facilitated transport of sodium salicylate across an artificial lipid membrane by Azone. J. Pharm. Pharmacol. 37, 725-727
36. 36 Bouwstra, J. and Boddé, H. (1995) Human SC barrier impairment by N-alkyl azacycloheptanones: a mechanistic study of drug flux enhancement, Azone mobility, and protein and lipid perturbation. In Percutaneous Penetration Enhancers (Smith, E. and Maibach, H., eds), pp. 137-157, CRC Press
37. 37 Harrison, J.E. et al. (1996) The relative effect of Azone® and Transcutol® on permeant diffusivity and solubility in human stratum corneum. Pharm. Res. 13, 542-546
38. 38 Tsai, J. et al. (1996) Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors. J. Pharm. Sci. 85, 643-648
39. 39 Khavari, P. (1997) Therapeutic gene delivery to the skin. Mol. Med. Today 3, 533-538
40. 40 Pettit, D. and Gombotz, W. (1998) The development of site-specific drug-delivery systems for protein and peptide biopharmaceuticals. Trends Biotechnol. 16, 343-349
41. 41 Berner, B. and Dinh, S. (1998) Electronically Controlled Drug Delivery, CRC Press
42. 42 Guy, R. (1992) Advanced Drug Delivery Reviews. Theme Issue: Iontophoresis, Elsevier Science
43. 43 Guy, R. et al. (2000) Iontophoresis: electrorepulsion and electroosmosis. J. Control. Release 64, 129-132
44. 44 Green, P.G. et al. (1991) Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro. Pharm. Res. 8, 1113-1120
45. 45 Merino, V. et al. (1999) Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil. Pharm. Res. 16, 758-761
46. 46 Marro, D. et al. (2000) Iontophoretic permselectivity of human skin: determination of the isoelectric point. Proc. Intl. Symp. Control. Rel. Bioact. Mater. 27 (CD-ROM)
47. 47 Burnette, R.R. and Marrero, D. (1986) Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin. J. Pharm. Sci. 75, 738-743
48. 48 Gibson, L.E. and Cooke, R.E. (1959) A test for the concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Paediatrics 23, 545-549
49. 49 Zempsky, W. et al. (1998) Lidocaine iontophoresis for topical anesthesia before intravenous line placement in children. J. Pediatr. 132, 1061-1063
50. 50 DeCou, J. et al. (1999) Iontophoresis: a needle-free electrical system of local anesthesia delivery for pediatric surgical office procedures. J. Pediatr. Surg. 34, 946-949
51. 51 Kim, M. et al. (1999) A randomized clinical trial of dermal anesthesia by iontophoresis for peripheral intravenous catheter placement in children. Ann. Emerg. Med. 33, 395-399
52. 52 Glikfeld, P. et al. (1989) Noninvasive sampling of biological fluids by iontophoresis. Pharm. Res. 6, 988-990
53. 53 Rao, G. et al. (1995) Reverse iontophoresis: noninvasive glucose monitoring in vivo in humans. Pharm. Res. 12, 1869-1873
54. 54 Merino, V. et al. (1999) Noninvasive sampling of phenylalanine by reverse iontophoresis. J. Control. Release 61, 65-69
55. 55 Guy R.H. (1995) A sweeter life for diabetics? Nat. Med. 1, 1198
56. 56 Kurnik, R. et al. (1998) Design and simulation of a reverse iontophoretic glucose monitoring device. J. Electrochem. Soc. 145, 4119-4125
57. 57 Tamada, J. et al. (1995) Measurement of glucose in diabetic subjects using noninvasive transdermal extraction. Nat. Med. 1, 1198-1201
58. 58 Tamada, J. et al. (1999) Noninvasive glucose monitoring. J. Am. Med. Assoc. 282, 1839-1844
59. 59 Turner, N.G. et al. (1997) Iontophoresis of poly-L-lysines: the role of molecular weight? Pharm. Res. 14, 1322-1331
60. 60 Guy, R.H. (1998) Iontophoresis - recent developments. J. Pharm. Pharmacol. 50, 371-374
61. 61 Jadoul, A. et al. (1995) Quantification and localization of fentanyl and TRH delivered by iontophoresis in the skin. Int. J. Pharm. 120, 221-228
62. 62 Scott, E.R. et al. (1992) Direct imaging of ionic pathways in stratum corneum using scanning electrochemical microscopy. Solid State Ionics 53-56, 176-183
63. 63 Prausnitz, M. (1995) Electroporation. In Electronically Controlled Drug Delivery (Berner, B. and Dinh, S., eds), pp. 185-214, CRC Press
64. 64 Tsong, T. (1991) Electroporation of cell membranes. Biophys. J. 60, 297-306
65. 65 Prausnitz, M. et al. (1993) Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc. Natl. Acad. Sci. U. S. A. 90, 10504-10508
66. 66 Bommannan, D. et al. (1994) Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro. Pharm. Res. 11, 1809-1814
67. 67 Jadoul, A. et al. (1998) Transdermal alniditan delivery by skin electroporation. J. Control. Release 54, 265-272
68. 68 Wang, S. et al. (1998) Transdermal delivery of cyclosporin-A using electroporation. J. Control. Release 50, 61-70
69. 69 Regnier, V. et al. (1999) Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation. Int. J. Pharm. 184, 147-156
70. 70 Camel, E. (1995) Ultrasound. In Percutaneous Penetration Enhancement (Smith, E. and Maibach, H., eds), pp. 369-382, CRC Press
71. 71 Kost, J. (1995) Phonophoresis. In Electronically Controlled Drug Delivery (Berner, B. and Dinh, S., eds), pp. 215-228, CRC Press
72. 72 Mitragotri, S. et al. (1995) A mechanistic study of ultrasonically enhanced transdermal drug delivery. J. Pharm. Sci. 84, 697-706
73. 73 Mitragotri, S. et al. (1996) Transdermal drug delivery using low-frequency sonophoresis. Pharm. Res. 13, 411-420
74. 74 Menon, G. et al. (1994) High-frequency sonophoresis: permeation pathways and structural basis for enhanced permeability. Skin Pharmacol. 7, 130-139
75. 75 Bommannan, D. et al. (1992) Sonophoresis II. Examination of the mechanism (s) of ultrasound-enhanced transdermal drug delivery. Pharm. Res. 9, 1043-1047
76. 76 Mitragotri, S. et al. (1995) Ultrasound-mediated transdermal protein delivery. Science 269, 850-853
77. 77 Tachibana, K. (1992) Transdermal delivery of insulin to alloxan-diabetic rabbits by ultrasound exposure. Pharm. Res. 9, 952-954
78. 78 Svedman, P. et al. (1996) Passive drug diffusion via standardized skin mini-erosion; methodological aspects and clinical findings with new device. Pharm. Res. 13, 1354-1359
79. 79 Meehan, E. et al. (1996) A microinfusor device for the delivery of therapeutic levels of peptides and macromolecules. J. Control. Release 46, 107-116
80. 80 Ciernik, I. et al. (1996) Puncture-mediated gene transfer to the skin. Hum. GeneTher. 7, 893-899
81. 81 Henry, S. et al. (1998) Microfabricated microneedles: a novel approach to transdermal drug delivery. J. Pharm. Sci. 87, 922-925
82. 82 Burkoth, T. et al. (1999) Transdermal and transmucosal powdered drug delivery. Crit. Rev.Ther. Drug Carrier Syst. 16, 331-384
83. 83 Cleary, G. (1993) Transdermal delivery systems: a medical rationale. In Topical Drug Bioavailability, Bioequivalence and Penetration (Shah, V. and Maibach, H., eds), pp, 17-68, Plenum Press